Laboratory Workup for 1-Month-Old Infant with TcB 10.2 mg/dL
For a 1-month-old infant with a transcutaneous bilirubin of 10.2 mg/dL, you should order: total serum bilirubin (TSB) with direct/conjugated bilirubin, complete blood count with smear, blood type and Coombs test (if not previously obtained), and check the newborn thyroid and galactosemia screening results. 1
Why This Specific Panel
The AAP guidelines are explicit about jaundice persisting at or beyond 3 weeks of age. At 1 month (4 weeks), this infant falls into a specific high-risk category that requires evaluation for cholestasis and underlying metabolic disorders 1.
Essential Initial Tests
Total and direct (or conjugated) bilirubin: This is the critical first step to rule out cholestasis, which can indicate serious hepatobiliary disease. The direct bilirubin measurement distinguishes between physiologic jaundice and pathologic causes requiring urgent intervention 1.
Complete blood count with peripheral smear: Identifies hemolytic causes including red cell morphology abnormalities and evidence of ongoing hemolysis 1.
Blood type and Coombs test: If not obtained with cord blood, this identifies ABO or Rh incompatibility as a hemolytic cause 1.
Newborn screening results: Specifically check thyroid function and galactosemia screening, as hypothyroidism and galactosemia are treatable causes of prolonged jaundice that can lead to serious morbidity if missed 1.
Additional Testing Based on Initial Results
If the direct bilirubin is elevated, immediately add:
- Urinalysis and urine culture
- Evaluation for sepsis based on clinical presentation 1
If jaundice remains unexplained or TSB is rising, consider adding:
- Reticulocyte count
- G6PD enzyme activity (particularly important given that G6PD deficiency caused hyperbilirubinemia in 31.5% of infants who developed kernicterus in one series) 1
- End-tidal carbon monoxide (ETCOc) if available 1
Critical Clinical Context
The transcutaneous reading of 10.2 mg/dL requires confirmation with serum bilirubin before making treatment decisions. While TcB is excellent for screening (sensitivity 74-100% across studies), it should not be used alone for management decisions 2. The AAP guidelines explicitly state that treatment decisions must be based on TSB levels, not TcB 3.
At 1 month of age, any jaundice warrants investigation because:
- Physiologic jaundice should have resolved by 2-3 weeks in term infants
- Persistent jaundice suggests pathologic causes including cholestasis, hemolysis, hypothyroidism, or metabolic disorders
- These conditions require specific interventions to prevent long-term morbidity
Common Pitfalls to Avoid
Do not rely solely on the TcB value of 10.2 mg/dL for clinical decisions. While research shows TcB correlates well with TSB (r=0.8-0.91), it tends to underestimate TSB by approximately 0.7 mg/dL 4, 5.
Do not skip the direct bilirubin measurement in a 1-month-old infant. Cholestasis presenting at this age can indicate biliary atresia, which requires surgical intervention (Kasai procedure) ideally before 60 days of life to preserve liver function and prevent cirrhosis.
Do not forget to verify newborn screening results were completed and review them specifically for thyroid and galactosemia results, as these are actionable causes of prolonged jaundice 1.